Human chorionic gonadotropin (hCG) and prevention of breast cancer

Molecular and Cellular Endocrinology

Volumn 269, Issue 1-2 SPEC. ISS., 2007, Pages 93-98

  Janssens, Jaak Ph ^a   Russo, José ^d   Russo, Irma ^d   Michiels, Luc ^a   Donders, Gilbert ^b   Verjans, Marcel ^b   Riphagen, Ine ^b   Van den Bossche, Thierry ^b   Deleu, Marijke ^b   Sieprath, Peter ^c  

^a HASSELT UNIVERSITY   (Belgium)

^b Heilig Hart Ziekenhuis   (Belgium)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d Philadelphia Fox Chase Cancer Centre   (United States)

Author keywords

Breast cancer; Human chorionic gonadotropin; Recombinant hCG

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; DOXORUBICIN; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MITOMYCIN C; PACLITAXEL; PROGESTERONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST BIOPSY; BREAST CANCER; CELL INVASION; CELL PROLIFERATION; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; PILOT STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; NEOPLASM METASTASIS; POSTMENOPAUSE;

EID: 33947591136     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.06.015     Document Type: Article

References (31)

1. Alvarado N.E., Ho T., Alvarado M.C., Russo I.H., and Russo J. Human Chorionic Gonadotropîn (hCG) inhibits proliferation and induces the expression of inhibin in human breast epithelial cells (HBEC) in vitro. Proc. Am. Assoc. Cancer Res. 22 (1992) 1672a
2. Alvarado M.V., Russo J., and Russo I.H. Immunolocalization of inhibin in the mammary gland of rats treated with hCG. J. Histochem. Cytochem. 41 (1993) 29-34
3. Alvarado M.E., Alvarado N.E., Russo J., and Russo I.H. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vivo. In Vitro 30A (1994) 4-8
4. Anderson M.J., and Kramer B.S. Adjuvant systemic therapy for early stage breast cancer. In: Bland K.I., and Copeland III E.M. (Eds). The breast: Comprehensive Management of Benign and Malignant Disease (1991), W.B. Saunders Co., Philadelphia 817-842
5. Bahl O.P. Chemistry of human chorionic gonadotropin. In: Li C.H. (Ed). Hormonal Proteins and Peptides (1973), Academic Press, New York 171-199
6. Baum M., Wilson A.J., and Ebbs S.R. The role of adjuvant endocrine therapy in primary breast cancer. In: Salmon S.E. (Ed). Adjuvant Therapy of Cancer V (1987), Grune and Stratton, Orlando 377-390
7. Birken, S., Krichevsky, A., O'Connor, J., Lustbader, J., Canfield, R. Chemistry and immunochemistry of hCG, its subunits and its fragments, in: Chin, W.W., Boime, I. (Eds.), Glycoprotein hormones, 1990, pp. 45-61.
8. Coombes R.C., Chilvers C., and Powles T.J. Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer. In: Jones S.E., and Salmon S.E. (Eds). Adjuvant Therapy of Cancer IV (1984), Grune and Stratton, Orlando 340-357
9. Guo S., Russo I.H., Lareef M.H., and Russo J. Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int. J. Oncol. 24 (2004) 399-407
10. Henderson I.C. Endocrine therapy of metastatic breast cancer. In: Harris J.R., Hellman S., Henderson I.C., and Kinne D.W. (Eds). Breast Diseases (1987), J.B. Lippincott, Philadelphia 559-603
11. Janssens J.P., Verlinden I., Gungor N., Raus J., and Michiels L. Protein biomarkers for breast cancer prevention. Eur. J. Cancer Prev. 13 (2004) 307-317
12. Jordan V.C., Fritz N.F., and Tormey D.C. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antitrombin III. Cancer Res. 47 (1987) 4517-4519
13. Keutman H.T., Dawson B., Bishop W.H., and Ryan R.J. Structure of human luteinizing hormone alpha subunit. Endocrinol. Res. Commun. 5 (1978) 57-70
14. Knabbe C., Lippman M.E., Wakefield I., Flanders K.C., Kasid A., Derynck R., et al. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48 (1987) 417-428
15. Lojun S., Bao S., Lei Z.M., and Rao C.V. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting gthe premise that hCG protects women against breast cancer. Biol. Reprod. 57 (1997) 1202-1210
16. Matzuk M.M., Finegold M.J., Su J.-G.J., Husueh A.J.W., and Bradley A. Alpha-inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360 (1992) 313-319
17. Meduri G., Chamaux N., Spyratos F., Hacene K., Loosfelt H., and Milgrom E. Luteinizing hormone receptor status and clinical, pathologic, and prognostid features in patients with breast carcinomas. Cancer 97 (2003) 1810-1816
18. Palshoff T., Mouridsen H.T., and Daehmfeldt J.L. Adjuvant endocrine therapy of primary operable breast cancer: report on the Copenhagen Breast Cancer Trials. Eur. J. Cancer (1980) 183-187 (Suppl.)
19. Pierce J.G., and Parsons T.F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 50 (1981) 465-495
20. Rao C.V., Li X., Manna S.K., Lei Z.M., and Aggarwal B.B. Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation. J. Biol. Chem. 11 (2004) 25503-25510
21. Russo J., and Reina D. Human chorionic gonadotropin hormone (hCG) as an inhibitor growth facto on MCF-7 cells. Proc. Am. Assoc. Cancer Res. 26 (1985) 108a
22. Russo J., and Russo I.H. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol. Biomarkers Prev. 3 (1994) 353-364
23. Russo I.H., and Russo J. Role of hCG and inhibin in breast cancer. Int. J. Oncol. 4 (1994) 306-427 (Review)
24. Russo I.H., Kozalka M., and Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 11 (1990) 1840-1855
25. Russo I.H., Koszalka M., Gimotty P.A., and Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br. J. Cancer 62 (1990) 243-247
26. Russo I.H., Koszalka M., and Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J. Natl. Cancer Inst. 82 (1990) 1286-1289
27. Russo I.H., Koszalka M., and Russo J. Comparative study on the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br. J. Cancer 64 (1991) 481-484
28. Sairam M.R. Les hormones gonadotropes de l'hypophyse humaine (FSH, LH et prolactine): structure et mechanisme d'action. In: Mauvais Jarvis P., and Sitruk-Ware R. (Eds). Medecine de la Reproduction (gynecologie endocrinienne). second ed. (1986), Flammarion Medecine/Sciences, Paris 41-57
29. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 92 (2000) 205-216
30. Veronesi U. Conservation surgery and irradiation in stages I and II disease at the Istituto Nazionali Tumori (Milan). In: Bland K.I., and Copeland III E.M. (Eds). The Breast: Comprehensve Management of Benign and Malignant Diseases (1991), W.B. Saunders Co., Philadelphia 804-808
31. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment (1979), WHO, Geneva